Kristofor K. Ellestad

Calgary, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

Journal: Nature cancer

Published: April 29, 2026

Internal regulation between constitutively expressed T cell co-inhibitory receptors BTLA and CD5 and tolerance in recent thymic emigrants.

Internal regulation between constitutively expressed T cell co-inhibitory receptors BTLA and CD5 and tolerance in recent thymic emigrants.

Journal: Open biology

Published: October 29, 2024

A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection.

A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection.

Journal: NPJ vaccines

Published: April 04, 2024

CD8 T Cells Target Antigen Cross-Presented by Bone Marrow Derived Cells to Induce Bystander Rejection of Grafts Lacking the Cognate Peptide-MHC.

CD8 T Cells Target Antigen Cross-Presented by Bone Marrow Derived Cells to Induce Bystander Rejection of Grafts Lacking the Cognate Peptide-MHC.

Journal: Cell transplantation

Published: November 11, 2022

Extremely short bioavailability and fast pharmacodynamic effects of pMHC-based nanomedicines.

Extremely short bioavailability and fast pharmacodynamic effects of pMHC-based nanomedicines.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: May 07, 2021

Increased yields and biological potency of knob-into-hole-based soluble MHC class II molecules.

Increased yields and biological potency of knob-into-hole-based soluble MHC class II molecules.

Journal: Nature communications

Published: July 12, 2019

Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity.

Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity.

Journal: The Journal of clinical investigation

Published: May 29, 2019

Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity.

Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity.

Journal: ACS nano

Published: November 29, 2018

Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1.

Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1.

Journal: Frontiers in immunology

Published: October 21, 2017

PD-1 Controls Tonic Signaling and Lymphopenia-Induced Proliferation of T Lymphocytes.

PD-1 Controls Tonic Signaling and Lymphopenia-Induced Proliferation of T Lymphocytes.

Journal: Frontiers in immunology

Published: May 31, 2017

Two Strikes and You're Out? The Pathogenic Interplay of Coinhibitor Deficiency and Lymphopenia-Induced Proliferation.

Two Strikes and You're Out? The Pathogenic Interplay of Coinhibitor Deficiency and Lymphopenia-Induced Proliferation.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: November 08, 2016

PD-1 is not required for natural or peripherally induced regulatory T cells: Severe autoimmunity despite normal production of regulatory T cells.

PD-1 is not required for natural or peripherally induced regulatory T cells: Severe autoimmunity despite normal production of regulatory T cells.

Journal: European journal of immunology

Published: March 24, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026